Liver Diseases  >>  EZN-2968  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EZN-2968 / Enzon
NCT01120288: A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Checkmark In pts with refractory solid tumors
Dec 2013 - Dec 2013: In pts with refractory solid tumors
Completed
1
10
US
EZN-2968
National Cancer Institute (NCI)
Neoplasms, Liver Metastases
 
09/13

Download Options